Cargando…

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

Detalles Bibliográficos
Autores principales:	Greene, Julia, Schneble, Erika, Berry, John, Trappey, Alfred, Vreeland, Timothy, Clifton, Guy, McGuire, William, Maxwell, George, Ponniah, Sathibalan, Peoples, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288735/ http://dx.doi.org/10.1186/2051-1426-2-S3-P74

Ejemplares similares

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine
por: Jackson, Doreen, et al.
Publicado: (2015)

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
por: Jackson, Doreen O., et al.
Publicado: (2016)

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
por: Greene, Julia, et al.
Publicado: (2014)

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients
por: Berry, John S, et al.
Publicado: (2013)

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
por: Schneble, Erika J, et al.
Publicado: (2013)

Final analysis of a phase I/IIa trial of the folate‐binding protein‐derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients
por: Brown, Tommy A., et al.
Publicado: (2019)

Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development
por: Berry, JS, et al.
Publicado: (2017)

Analysis of Clinical and Pathologic Factors of Pure, Flat Epithelial Atypia on Core Needle Biopsy to Aid in the Decision of Excision or Observation
por: Berry, John S, et al.
Publicado: (2016)

ASO Author Reflections: The Tumor Lysate, Particle-Loaded, Dendritic Cell Vaccine for Advanced-Stage Melanoma: Reflection on Personalized Cancer Vaccination
por: Adams, Alexandra M., et al.
Publicado: (2021)

A role for G-CSF and GM-CSF in nonmyeloid cancers
por: Aliper, Alexander M, et al.
Publicado: (2014)

GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019)

Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages
por: Muller, Ittai B., et al.
Publicado: (2023)

G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)

Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023)

Preclinical testing of a novel personalized cancer vaccine for all solid tumors and all patients
por: Jackson, Doreen, et al.
Publicado: (2015)

Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes
por: Vreeland, Timothy J, et al.
Publicado: (2017)

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
por: Brown, Tommy A., et al.
Publicado: (2020)

Deficiencies of GM-CSF and Interferon γ Link Inflammation and Cancer
por: Enzler, Thomas, et al.
Publicado: (2003)

GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
por: Kumar, Anil, et al.
Publicado: (2022)

The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer
por: Weber, Achim, et al.
Publicado: (2008)

Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA
por: Li, Jin-Tao, et al.
Publicado: (2022)

GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)

Development of Dendritic Cells from GM-CSF(-/-) Mice in vitro : GM-CSF Enhances Production and Survival of Cells
por: Ni, Keping, et al.
Publicado: (2001)

MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer
por: Ma, Ning, et al.
Publicado: (2017)

Response to Treatment with TNFα Inhibitors in Rheumatoid Arthritis Is Associated with High Levels of GM-CSF and GM-CSF(+) T Lymphocytes
por: Bystrom, Jonas, et al.
Publicado: (2017)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

Correction To: Dietary folate drives methionine metabolism to promote cancer development by stabilizing MAT IIA
por: Li, Jin-Tao, et al.
Publicado: (2022)

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

A Review of GM-CSF Therapy in Sepsis
por: Mathias, Brittany, et al.
Publicado: (2015)

The efficacy and safety of targeting GM-CSF in arthritis
por: Bykerk, Vivian P
Publicado: (2020)

GM-CSF: Orchestrating the Pulmonary Response to Infection
por: McCormick, Thomas S., et al.
Publicado: (2022)

Role of GM-CSF in lung balance and disease
por: Chen, Yingzi, et al.
Publicado: (2023)

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence
por: Mittendorf, Elizabeth A., et al.
Publicado: (2016)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF
por: Hu, Zhiming, et al.
Publicado: (2010)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Deubiquitination of FBP1 by USP7 blocks FBP1–DNMT1 interaction and decreases the sensitivity of pancreatic cancer cells to PARP inhibitors
por: Cheng, Xiang, et al.
Publicado: (2021)

Borrelia miyamotoi FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions
por: Booth, Charles E., et al.
Publicado: (2022)

Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
por: Mukherjee, Bratati, et al.
Publicado: (2022)

Parallel Implementation of Katsevich's FBP Algorithm
por: Yang, Jiansheng, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_b39hl1kt9mdu8b8c15ahr0qhpn